Data pattern analysis for the individualised pretherapeutic identification of high-risk diffuse large B-cell lymphoma (DLBCL) patients by cytomics
Open Access
- 17 May 2004
- Vol. 59A (2) , 232-236
- https://doi.org/10.1002/cyto.a.20057
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessmentThe Lancet, 2003
- Pretherapeutic identification of high‐risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parametersCytometry Part B: Clinical Cytometry, 2003
- Immunophenotyping is an independent factor for risk stratification in AMLCytometry Part B: Clinical Cytometry, 2003
- Pharmacogenetics and the future of medical practiceJournal of Molecular Medicine, 2003
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Genomics and medicine: hopes and challengesGene Therapy, 2002
- Cluster analysis and display of genome-wide expression patternsProceedings of the National Academy of Sciences, 1998